Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Patent
1992-01-10
1993-06-22
Lilling, Herbert J.
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
435118, 435899, C12P 1716, C12R 156
Patent
active
052216250
ABSTRACT:
Described is a process for producing a new immunosuppressant, a C-19/C-22 cyclic hemiketal (Compound I) biotransformation analog of FR-900520, under novel fermentation conditions utilizing the novel microorganism, Streptomyces sp. (Merck Culture Collection MA6963) ATCC No. 55230. The macrolide immunosuppressant is useful in preventing human host rejection of foreign organ transplants, e.g. bone marrow, liver, lung, kidney and heart transplants.
REFERENCES:
patent: 3244592 (1966-04-01), Arai
patent: 4081531 (1978-03-01), Arai et al.
patent: 4242453 (1980-12-01), Umezawa et al.
patent: 4264607 (1981-04-01), Dewey et al.
patent: 4894344 (1990-01-01), Sugiyama et al.
"Catalogue of Bacteria and Phage" 17th ed. ATCC Ed. Gherna et al. 1989 p. 228 S. lavendulae.
J. Antibiotics A15, pp. 231-232, by Arai Jul. 31, 1962.
Arison Byron H.
Bernick Amy M.
Chen Shieh-Shung T.
Dezeny Georgette
Garrity George M.
Caruso Charles M.
Lilling Herbert J.
Merck & Co. , Inc.
North Robert J.
Thies J. Eric
LandOfFree
Cyclcic FR-900520 microbial biotransformation agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclcic FR-900520 microbial biotransformation agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclcic FR-900520 microbial biotransformation agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1440680